Somatic POLE proofreading domain mutation, immune response and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Background<br/> Precision cancer medicine depends on defining distinct tumour subgroups using biomarkers that may occur at very modest frequencies. One such subgroup comprises patients with exceptionally mutated (ultramutated) cancers caused by mutations that impair DNA polymerase epsilon (POL...
المؤلفون الرئيسيون: | Domingo, E, Freeman-Mills, L, Rayner, E, Glaire, M, Briggs, S, Koelzer, V, Frangou, E, Dutton, P, Kerr, R, Kerr, D, Tomlinson, I, Church, D, EPICOLON consortium |
---|---|
التنسيق: | Journal article |
منشور في: |
Lancet
2016
|
مواد مشابهة
-
POLE proofreading domain mutation defines a subset of immunogenic colorectal cancers with excellent prognosis
حسب: Glaire, MA, وآخرون
منشور في: (2016) -
POLE proofreading mutation, immune response and prognosis in endometrial cancer
حسب: Van Gool, I, وآخرون
منشور في: (2015) -
POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer
حسب: Klenerman, P, وآخرون
منشور في: (2015) -
Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues
حسب: Van Gool, I, وآخرون
منشور في: (2018) -
A panoply of errors: polymerase proofreading domain mutations in cancer
حسب: Rayner, E, وآخرون
منشور في: (2016)